Made available in DSpace on 2022-04-29T08:34:56Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-09-17; Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP); Non-responsiveness to anti-TNF-α therapies presents relevant rates in inflammatory bowel disease patients, presenting the need to find biomarkers involved in therapeutic efficacy. Herein, we demonstrate that higher levels of colonic formyl p...
Made available in DSpace on 2018-12-11T17:13:21Z (GMT). No. of bitstreams: 0 Previous issue date: 2017-10-01; Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP); Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq); Department of Biology Immunomorphology Laboratory São Paulo State University (UNESP) Institute of Biosciences Humanities and Exact Sciences (IBILCE) Campus São José do Rio...
Made available in DSpace on 2018-12-11T17:04:04Z (GMT). No. of bitstreams: 0 Previous issue date: 2016-09-01; TNF-α is involved in the mechanisms that initiate inflammatory bowel diseases (IBDs). Anti-TNF-α drugs, such as infliximab (IFX), cause non-responsiveness and side effects, indicating the need to investigate alternative therapies for these diseases. The anti-inflammatory protein, annexin A1 (AnxA1), has...